• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Clinical efficacy of WT1 peptide vaccination in patients with acute myelogenous leukemia and myelodysplastic syndrome.

作者信息

Yasukawa Masaki, Fujiwara Hiroshi, Ochi Toshiki, Suemori Koichiro, Narumi Hiroshi, Azuma Taichi, Kuzushima Kiyotaka

出版信息

Am J Hematol. 2009 May;84(5):314-5. doi: 10.1002/ajh.21387.

DOI:10.1002/ajh.21387
PMID:19338044
Abstract
摘要

相似文献

1
Clinical efficacy of WT1 peptide vaccination in patients with acute myelogenous leukemia and myelodysplastic syndrome.WT1肽疫苗接种对急性髓性白血病和骨髓增生异常综合征患者的临床疗效。
Am J Hematol. 2009 May;84(5):314-5. doi: 10.1002/ajh.21387.
2
[WT1 peptide-based immunotherapy].[基于WT1肽的免疫疗法]
Nihon Rinsho. 2005 Jun;63(6):1101-9.
3
[WT1 gene expression in patients with acute myelogenous leukemia or high risk myelodysplastic syndrome successfully treated with the CAG regimen].
Rinsho Ketsueki. 2002 Oct;43(10):960-2.
4
WT1 vaccination in AML and MDS: A pilot trial with synthetic analog peptides.WT1疫苗用于急性髓系白血病和骨髓增生异常综合征：一项合成类似物肽的试点试验。
Am J Hematol. 2015 Jul;90(7):602-7. doi: 10.1002/ajh.24014. Epub 2015 May 3.
5
Long-term WT1 peptide vaccination for patients with acute myeloid leukemia with minimal residual disease.针对伴有微小残留病的急性髓系白血病患者的长期WT1肽疫苗接种。
Leukemia. 2012 Jun;26(6):1410-3. doi: 10.1038/leu.2011.343. Epub 2011 Dec 13.
6
Wilms' tumor 1 message and protein expression in bone marrow failure syndrome and acute leukemia.肾母细胞瘤1信息及蛋白在骨髓衰竭综合征和急性白血病中的表达
Pathol Int. 2007 Oct;57(10):645-51. doi: 10.1111/j.1440-1827.2007.02153.x.
7
Low-dose cytosine arabinoside (Ara-C) therapy in the myelodysplastic syndromes and acute myelogenous leukemia.
Haematologica. 1987 Jan-Feb;72(1):61-5.
8
WT1 peptide vaccination following allogeneic stem cell transplantation in pediatric leukemic patients with high risk for relapse: successful maintenance of durable remission.WT1肽疫苗接种用于复发高危的小儿白血病患者异基因干细胞移植后：成功维持持久缓解
Leukemia. 2012 Mar;26(3):530-2. doi: 10.1038/leu.2011.226. Epub 2011 Aug 26.
9
Complete remission in a patient with recurrent acute myeloid leukemia induced by vaccination with WT1 peptide in the absence of hematological or renal toxicity.在无血液学或肾脏毒性的情况下，通过接种WT1肽诱导复发急性髓系白血病患者实现完全缓解。
Leukemia. 2004 Jan;18(1):165-6. doi: 10.1038/sj.leu.2403186.
10
[Clinical course of severe acquired aplastic anemia to myelodysplastic syndrome and acute leukosis].
Med Clin (Barc). 1995 Jul 8;105(6):224-6.

引用本文的文献

1
First-in-human study of WT1 recombinant protein vaccination in elderly patients with AML in remission: a single-center experience.在缓解期老年 AML 患者中进行 WT1 重组蛋白疫苗接种的首次人体研究：单中心经验。
Cancer Immunol Immunother. 2022 Dec;71(12):2913-2928. doi: 10.1007/s00262-022-03202-8. Epub 2022 Apr 27.
2
A Novel DNA Vaccine Platform Enhances Neo-antigen-like T Cell Responses against WT1 to Break Tolerance and Induce Anti-tumor Immunity.一种新型DNA疫苗平台增强针对WT1的类新抗原T细胞反应以打破耐受性并诱导抗肿瘤免疫。
Mol Ther. 2017 Apr 5;25(4):976-988. doi: 10.1016/j.ymthe.2017.01.022. Epub 2017 Feb 22.
3
Life after transplant: are we becoming high maintenance in AML?
移植后的生活：在急性髓系白血病中我们是否变得难以维持？
Bone Marrow Transplant. 2016 Nov;51(11):1423-1430. doi: 10.1038/bmt.2016.160. Epub 2016 Jun 20.
4
Review of the Results of WT1 Peptide Vaccination Strategies for Myelodysplastic Syndromes and Acute Myeloid Leukemia from Nine Different Studies.对九项不同研究中WT1肽疫苗接种策略治疗骨髓增生异常综合征和急性髓系白血病结果的综述。
Front Immunol. 2015 Feb 4;6:36. doi: 10.3389/fimmu.2015.00036. eCollection 2015.
5
Dendritic cell cancer vaccines: from the bench to the bedside.树突状细胞癌症疫苗：从实验室到临床应用
Rambam Maimonides Med J. 2014 Oct 29;5(4):e0024. doi: 10.5041/RMMJ.10158. eCollection 2014 Oct.
6
Active specific immunotherapy targeting the Wilms' tumor protein 1 (WT1) for patients with hematological malignancies and solid tumors: lessons from early clinical trials.针对血液系统恶性肿瘤和实体瘤患者的 Wilms 瘤蛋白 1（WT1）的主动特异性免疫治疗：来自早期临床试验的经验。
Oncologist. 2012;17(2):250-9. doi: 10.1634/theoncologist.2011-0240. Epub 2012 Jan 30.
7
Application of adoptive T-cell therapy using tumor antigen-specific T-cell receptor gene transfer for the treatment of human leukemia.应用肿瘤抗原特异性T细胞受体基因转移的过继性T细胞疗法治疗人类白血病。
J Biomed Biotechnol. 2010;2010:521248. doi: 10.1155/2010/521248. Epub 2010 May 5.
8
WT1 peptide vaccination in a CML patient: induction of effective cytotoxic T lymphocytes and significance of peptide administration interval.WT1 肽疫苗接种治疗慢性髓系白血病患者：诱导有效的细胞毒性 T 淋巴细胞和肽给药间隔的意义。
Med Oncol. 2011 Mar;28(1):219-30. doi: 10.1007/s12032-010-9425-3. Epub 2010 Jan 27.